Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia

File Description SizeFormat 
Manuscript 29_6_2016.docxAccepted version32.33 kBMicrosoft WordView/Open
Title: Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia
Authors: Claudiani, S
Apperley, JF
Deplano, S
Khorashad, J
Foroni, L
Palanicawandar, R
Perry, R
Milojkovic, D
Item Type: Journal Article
Issue Date: 28-Jul-2016
Date of Acceptance: 26-Jul-2016
URI: http://hdl.handle.net/10044/1/38635
DOI: https://dx.doi.org/10.1002/ajh.24495
ISSN: 1096-8652
Publisher: Wiley
Start Page: E480
End Page: E481
Journal / Book Title: American Journal of Hematology
Volume: 91
Issue: 11
Copyright Statement: © 2016 Wiley Periodicals, Inc. This is the accepted version of the following article: 'Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia', which has been published in final form at http://dx.doi.org/10.1002/ajh.24495.
Sponsor/Funder: Leuka
Imperial College Healthcare NHS Trust- BRC Funding
Leuka
National Institute for Health Research
Funder's Grant Number: na
RDB05 79560
Renew P45896 Core Grant 2014
NF-SI-0611-10275
Keywords: Immunology
1102 Cardiovascular Medicine And Haematology
Publication Status: Published
Appears in Collections:Department of Medicine
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons